|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00399620 |
|
Date of registration:
|
14/11/2006 |
|
Primary sponsor: |
|
|
Public title:
|
Chromogranin-A-Derived Peptides and Periodontitis in Diabetic Patients
|
|
Scientific title:
|
Chromogranin-A-Derived Peptides in the Gingival Crevicular Fluid and the Saliva of Diabetic Patients With or Without Periodontitis |
|
Date of first enrolment:
|
March 2008 |
|
Target sample size:
|
90 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT00399620 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
|
|
|
Countries of recruitment
|
|
France
| | | | | | | |
|
Contacts
|
|
Name:
|
Martine Soell, MD |
|
Address:
|
|
|
Telephone:
|
33.6.74.86.67.36 |
|
Email:
|
martine.soell@chru-strasbourg.fr |
|
Affiliation:
|
|
|
|
Name:
|
Martine Soell, MD |
|
Address:
|
|
|
Telephone:
|
33 6 74 86 67 36 |
|
Email:
|
martine.soell@chru-strasbourg.fr |
|
Affiliation:
|
|
|
|
Name:
|
Martine Soell, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Hôpitaux Universitaires de Strasbourg |
|
|
Key inclusion & exclusion criteria
|
Inclusion criteria:
- Patients from 20 to 80 years old
- A minimum of 10 teeth
- Healthy volunteers or diabetic patients with or without periodontitis
Exclusion criteria:
- a course of antibiotics
- a fungicidal therapy
- a corticotherapy
- a hormone therapy
- a pregnancy
- persons under guardianship
Age minimum:
20 Years
Age maximum:
80 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Periodontitis and Diabetitis
|
|
Intervention(s)
|
|
Procedure: Gingival crevicular fluid samples (this procedure is added to the subject usual medical follow-up).
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|